249 related articles for article (PubMed ID: 20493396)
1. Hematopoietic stem cell transplantation for chronic granulomatous disease.
Seger RA
Immunol Allergy Clin North Am; 2010 May; 30(2):195-208. PubMed ID: 20493396
[TBL] [Abstract][Full Text] [Related]
2. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
[TBL] [Abstract][Full Text] [Related]
3. Modern management of chronic granulomatous disease.
Seger RA
Br J Haematol; 2008 Feb; 140(3):255-66. PubMed ID: 18217895
[TBL] [Abstract][Full Text] [Related]
4. Successful hematopoietic stem cell transplantation in 2 children with X-linked chronic granulomatous disease from their unaffected HLA-identical siblings selected using preimplantation genetic diagnosis combined with HLA typing.
Goussetis E; Konialis CP; Peristeri I; Kitra V; Dimopoulou M; Petropoulou T; Vessalas G; Papassavas A; Tzanoudaki M; Kokkali G; Petrakou E; Spiropoulos A; Pangalos CG; Pantos K; Graphakos S
Biol Blood Marrow Transplant; 2010 Mar; 16(3):344-9. PubMed ID: 19835970
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature.
Del Giudice I; Iori AP; Mengarelli A; Testi AM; Romano A; Cerretti R; Macrì F; Iacobini M; Arcese W
Ann Hematol; 2003 Mar; 82(3):189-92. PubMed ID: 12634956
[TBL] [Abstract][Full Text] [Related]
6. Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation.
Parikh SH; Szabolcs P; Prasad VK; Lakshminarayanan S; Martin PL; Driscoll TA; Kurtzberg J
Pediatr Blood Cancer; 2007 Dec; 49(7):982-4. PubMed ID: 17941061
[TBL] [Abstract][Full Text] [Related]
7. Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis.
Burt RK; Barr W; Oyama Y; Traynor A; Slavin S
J Rheumatol Suppl; 2001 Oct; 64():42-8. PubMed ID: 11642504
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Stable long-term gene correction with low-dose radiation conditioning in murine X-linked chronic granulomatous disease.
Goebel WS; Pech NK; Dinauer MC
Blood Cells Mol Dis; 2004; 33(3):365-71. PubMed ID: 15528159
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
Connelly JA; Marsh R; Parikh S; Talano JA
J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S31-S39. PubMed ID: 29746680
[TBL] [Abstract][Full Text] [Related]
11. Sequential reduced- and full-intensity allografting using same donor in a child with chronic granulomatous disease and coexistent, significant comorbidity.
Nicholson JA; Wynn RF; Carr TF; Will AM
Bone Marrow Transplant; 2004 Dec; 34(11):1009-10. PubMed ID: 15489863
[No Abstract] [Full Text] [Related]
12. Gene therapy for chronic granulomatous disease.
Kume A; Dinauer MC
J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the autosomal recessive forms of chronic granulomatous disease.
Curnutte JT
Immunodefic Rev; 1992; 3(2):149-72. PubMed ID: 1554499
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells.
Zentilin L; Tafuro S; Serra C; Falaschi A; Giacca M
Ann Ist Super Sanita; 1998; 34(4):447-55. PubMed ID: 10234875
[TBL] [Abstract][Full Text] [Related]
16. Progress in gene therapy for chronic granulomatous disease.
Malech HL
J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
[TBL] [Abstract][Full Text] [Related]
17. Chronic granulomatous disease: recent advances in pathophysiology and treatment.
Seger RA
Neth J Med; 2010 Nov; 68(11):334-40. PubMed ID: 21116026
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
[TBL] [Abstract][Full Text] [Related]
19. Chronic granulomatous disease.
Dinauer MC; Orkin SH
Annu Rev Med; 1992; 43():117-24. PubMed ID: 1316094
[TBL] [Abstract][Full Text] [Related]
20. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]